• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.T 滤泡辅助细胞在 SARS-CoV-2 感染和疫苗接种的体液免疫反应中的作用。
J Leukoc Biol. 2022 Feb;111(2):355-365. doi: 10.1002/JLB.5MR0821-464R. Epub 2021 Nov 3.
2
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.SARS-CoV-2 特异性循环滤泡辅助 T 细胞与中和抗体相关,并在早期康复期间增加。
PLoS Pathog. 2021 Jul 16;17(7):e1009761. doi: 10.1371/journal.ppat.1009761. eCollection 2021 Jul.
3
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
4
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection.新冠病毒肺炎引起的高白细胞介素-6 水平与奥密克戎突破性感染急性期循环滤泡辅助 T 细胞频率增加和强烈的中和抗体反应相关。
Front Immunol. 2024 Apr 17;15:1377014. doi: 10.3389/fimmu.2024.1377014. eCollection 2024.
5
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.既往感染与疫苗接种产生针对 SARS-CoV-2 变异株的中和抗体效力。
mBio. 2021 Dec 21;12(6):e0265621. doi: 10.1128/mBio.02656-21. Epub 2021 Dec 7.
6
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.COVID-19 恢复期个体中的 Spike 特异性循环滤泡辅助 T 细胞和交叉中和抗体反应。
Nat Microbiol. 2021 Jan;6(1):51-58. doi: 10.1038/s41564-020-00824-5. Epub 2020 Nov 16.
7
Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations.不同序贯 COVID-19 疫苗接种诱导的不同 BCR 利用和 T 细胞激活。
mBio. 2024 Oct 16;15(10):e0142924. doi: 10.1128/mbio.01429-24. Epub 2024 Sep 9.
8
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后,需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
9
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.高亲和力、中和 SARS-CoV-2 的抗体可以在没有滤泡辅助 T 细胞的情况下产生。
Sci Immunol. 2022 Feb 4;7(68):eabl5652. doi: 10.1126/sciimmunol.abl5652.
10
TIGITTfh show poor B-helper function and negatively correlate with SARS-CoV-2 antibody titre.TIGITTfh显示出较差的B辅助功能,并且与SARS-CoV-2抗体滴度呈负相关。
Front Immunol. 2024 May 29;15:1395684. doi: 10.3389/fimmu.2024.1395684. eCollection 2024.

引用本文的文献

1
Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months.接种灭活新冠病毒疫苗TURKOVAC可诱导长达8个月的持久体液免疫和细胞免疫反应。
Front Med (Lausanne). 2025 Apr 28;12:1524393. doi: 10.3389/fmed.2025.1524393. eCollection 2025.
2
Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination.抗原特异性 T 辅助细胞和细胞因子谱可预测对 SARS-CoV-2 加强疫苗接种的细胞和体液反应的强度和持久性。
Front Immunol. 2024 Aug 29;15:1423766. doi: 10.3389/fimmu.2024.1423766. eCollection 2024.
3
Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS-CoV-2 Through Mutant Bacteriophage Qβ-Receptor Binding Domain Conjugate.通过突变噬菌体Qβ受体结合域缀合物诱导针对多种SARS-CoV-2变体的持久B细胞和T细胞免疫。
Adv Healthc Mater. 2024 Aug;13(20):e2302755. doi: 10.1002/adhm.202302755. Epub 2024 May 17.
4
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection.新冠病毒肺炎引起的高白细胞介素-6 水平与奥密克戎突破性感染急性期循环滤泡辅助 T 细胞频率增加和强烈的中和抗体反应相关。
Front Immunol. 2024 Apr 17;15:1377014. doi: 10.3389/fimmu.2024.1377014. eCollection 2024.
5
Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia.特发性CD4淋巴细胞减少症患者对SARS-CoV-2 mRNA疫苗的免疫反应。
J Allergy Clin Immunol. 2024 Feb;153(2):503-512. doi: 10.1016/j.jaci.2023.10.012. Epub 2023 Oct 28.
6
Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV.低水平的既往人冠状病毒(HCoV-NL63)特异性 T 细胞频率与 HIV 感染者的 SARS-CoV-2 特异性 T 细胞反应受损相关。
Front Immunol. 2024 Jan 26;14:1291048. doi: 10.3389/fimmu.2023.1291048. eCollection 2023.
7
Destabilisation of T cell-dependent humoral immunity in sepsis.脓毒症中 T 细胞依赖性体液免疫的不稳定。
Clin Sci (Lond). 2024 Jan 10;138(1):65-85. doi: 10.1042/CS20230517.
8
A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV.第三剂(加强针)灭活 SARS-CoV-2 疫苗可在 HIV 感染者中引发免疫原性和滤泡辅助 T 细胞反应。
Front Immunol. 2023 Nov 15;14:1264160. doi: 10.3389/fimmu.2023.1264160. eCollection 2023.
9
Antigen-Specific CD4 T Cell and B Cell Responses to Borrelia burgdorferi.针对伯氏疏螺旋体的抗原特异性 CD4 T 细胞和 B 细胞应答。
J Immunol. 2023 Sep 15;211(6):994-1005. doi: 10.4049/jimmunol.2200890.
10
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines.严重急性呼吸综合征冠状病毒2:免疫、当前疫苗面临的挑战以及黏膜疫苗的新视角
Vaccines (Basel). 2023 Apr 15;11(4):849. doi: 10.3390/vaccines11040849.

本文引用的文献

1
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals.健康个体和免疫功能低下个体对SARS-CoV-2 mRNA疫苗的生发中心反应。
Cell. 2022 Mar 17;185(6):1008-1024.e15. doi: 10.1016/j.cell.2022.01.027. Epub 2022 Feb 2.
2
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans.SARS-CoV-2 mRNA 疫苗可在人体内引发强烈且持久的滤泡辅助性 T 细胞反应。
Cell. 2022 Feb 17;185(4):603-613.e15. doi: 10.1016/j.cell.2021.12.026. Epub 2021 Dec 23.
3
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.抗 CD20 治疗的多发性硬化症患者接种 SARS-CoV-2 mRNA 疫苗后的细胞和体液免疫反应。
Nat Med. 2021 Nov;27(11):1990-2001. doi: 10.1038/s41591-021-01507-2. Epub 2021 Sep 14.
4
Rapid induction of antigen-specific CD4 T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.快速诱导抗原特异性 CD4 T 细胞与对 SARS-CoV-2 mRNA 疫苗接种的协调体液和细胞免疫有关。
Immunity. 2021 Sep 14;54(9):2133-2142.e3. doi: 10.1016/j.immuni.2021.08.001. Epub 2021 Aug 13.
5
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.SARS-CoV-2 特异性循环滤泡辅助 T 细胞与中和抗体相关,并在早期康复期间增加。
PLoS Pathog. 2021 Jul 16;17(7):e1009761. doi: 10.1371/journal.ppat.1009761. eCollection 2021 Jul.
6
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.无论住院时新冠病情严重程度如何,新冠病毒2型特异性体液免疫和细胞免疫均可持续9个月。
Clin Transl Immunology. 2021 Jul 5;10(7):e1306. doi: 10.1002/cti2.1306. eCollection 2021.
7
CD4 T cells that help B cells - a proposal for uniform nomenclature.辅助 B 细胞的 CD4 T 细胞——统一命名建议。
Trends Immunol. 2021 Aug;42(8):658-669. doi: 10.1016/j.it.2021.06.003. Epub 2021 Jul 6.
8
Evidence for antibody as a protective correlate for COVID-19 vaccines.针对 COVID-19 疫苗,抗体作为一种保护相关因素的证据。
Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24.
9
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.SARS-CoV-2 mRNA 疫苗可诱导持久的人体生发中心反应。
Nature. 2021 Aug;596(7870):109-113. doi: 10.1038/s41586-021-03738-2. Epub 2021 Jun 28.
10
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody.从早期 COVID-19 康复患者中分离出来的强效 SARS-CoV-2 中和抗体 SC31 的 Fc 介导的效应功能,是该抗体发挥最佳治疗效果的关键。
PLoS One. 2021 Jun 23;16(6):e0253487. doi: 10.1371/journal.pone.0253487. eCollection 2021.

T 滤泡辅助细胞在 SARS-CoV-2 感染和疫苗接种的体液免疫反应中的作用。

T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.

机构信息

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.

出版信息

J Leukoc Biol. 2022 Feb;111(2):355-365. doi: 10.1002/JLB.5MR0821-464R. Epub 2021 Nov 3.

DOI:10.1002/JLB.5MR0821-464R
PMID:34730247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8667651/
Abstract

Vaccination remains the most effective mechanism to reduce the impact of COVID-19. Induction of neutralizing antibodies is a strong correlate of protection from infection and severe disease. An understanding of the cellular events that underpin the generation of effective neutralizing antibodies is therefore key to the development of efficacious vaccines that target emerging variants of concern. Analysis of the immune response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and vaccination has identified circulating T follicular helper cells (cT ) as a robust correlate of the neutralizing antibody response. Here, we discuss the analysis of cT cells and their lymphoid counterparts in human humoral immune responses during COVID-19, and in response to vaccination with SARS-CoV-2 spike. We discuss the phenotypic heterogeneity of cT cells and the utility of cT subsets as informative biomarkers for development of humoral immunity. We posit that the analysis of the most effective cT will be critical to inducing durable immunity to new variants of SARS-CoV-2.

摘要

接种疫苗仍然是减少 COVID-19 影响的最有效机制。中和抗体的诱导是防止感染和严重疾病的强有力相关因素。因此,了解支持产生有效中和抗体的细胞事件对于开发针对新出现的关注变异株的有效疫苗至关重要。对严重急性呼吸系统综合征冠状病毒 2 (SARS-CoV-2) 感染和疫苗接种的免疫反应分析表明,循环滤泡辅助 T 细胞 (cT) 是中和抗体反应的有力相关因素。在这里,我们讨论了在 COVID-19 期间和对 SARS-CoV-2 刺突蛋白进行疫苗接种时,cT 细胞及其淋巴样对应物在人类体液免疫反应中的分析。我们讨论了 cT 细胞的表型异质性以及 cT 亚群作为体液免疫发展的信息生物标志物的实用性。我们假设,对最有效的 cT 的分析对于诱导对 SARS-CoV-2 新变异株的持久免疫力至关重要。